Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cell Therapeutics presents data on metabolism of CT-2103

April 23, 2002

New Chiron compounds reportedly useful for angiogenesis-related conditions

April 22, 2002

Tricyclic protein farnesyltransferase inhibitors with antiproliferative activity

April 22, 2002

Phase III trial of Affinitac in combination with Gemzar/cisplatin in NSCLC

April 22, 2002

Takeda presents new orally active antitumor agent for HER2-positive cancers

April 22, 2002

Small-molecule GnRH antagonist with good oral bioavailability presented at AACR meeting

April 22, 2002

Small-molecule inhibitors of FAH designed at Bayer as potential agents for NSCLC

April 22, 2002

CKD-732 examined for pharmacokinetic and metabolic profile in vitro and in vivo

April 22, 2002

All four components of PHY-906 necessary for biological activity as chemotherapy adjuvant

April 22, 2002

Lead Androgenics compound blocks androgen receptor activation at an early step

April 22, 2002

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026